China has revised its legal framework to promote compulsory licenses for patented medicines to meet public health needs. The government is considering issuing a compulsory license for tenofovir, a medicine recommended for first line treatment of HIV/AIDS, which is sold under the brand name Viread by Gilead. As reported by Reuters, the Chinese chemical firms [...]
↧